Skip to main content
SpringerLink
Log in

The Focus for Pharmaceutical Knowledge

The Proceedings of the Sixth International Meeting of Pharmaceutical Physicians Brighton, England, June 1987

  • Conference proceedings
  • © 1988
  • Latest edition

Overview

Editors:
  1. Denis Burley

    1. Ciba-Geigy Pharmaceuticals, IFAPP, Horsham, England

    View editor publications

    You can also search for this editor in PubMed   Google Scholar

  2. Christobel Haward
    View editor publications

    You can also search for this editor in PubMed   Google Scholar

  3. Brenda Mullinger
    View editor publications

    You can also search for this editor in PubMed   Google Scholar

  • 616 Accesses

This is a preview of subscription content, log in via an institution to check access.

Access this book

Log in via an institution

Other ways to access

Licence this eBook for your library

Institutional subscriptions

Table of contents (41 papers)

  1. Front Matter

    Pages i-xvi
    Download chapter PDF

  2. Quality of life

    • G. Teeling Smith
    Pages 1-10

  3. Contributions of the pharmaceutical industry to health care

    • D. A. K. Black
    Pages 11-15

  4. Failings of the pharmaceutical industry

    • C. Medawar
    Pages 16-22

  5. Improving health care by improving the image of the pharmaceutical industry

    • H. Schwartz
    Pages 23-27

  6. General discussion on pharmaceuticals and health care

    • Denis Burley, Christobel Haward, Brenda Mullinger
    Pages 28-37

  7. The future of the pharmaceutical industry

    • L. C. Hoff
    Pages 38-45

  8. Genes, monoclonal antibodies and cancer

    • K. Sikora
    Pages 46-52

  9. Development of biological agents through DNA technology

    • N. Stebbing
    Pages 53-65

  10. Creating a comprehensive and accurate database of efficacy and safety information

    • R. N. Smith
    Pages 66-72

  11. Who needs good clinical practice?

    • P. A. Nicholson
    Pages 73-75

  12. Checks expected by regulatory authorities

    • P. Leber
    Pages 76-82

  13. Good clinical practice

    • B. A. Gennery
    Pages 83-88

  14. Clinical pharmacology in industry

    • D. Jackson
    Pages 89-94

  15. Multicentre trials in drug development: good? necessary?

    • P. E. Lucchelli
    Pages 95-101

  16. Phase IV studies: experience in Spain

    • F. G. Alonso
    Pages 102-106

  17. Influence of methodology on the results of phase IV studies

    • E. Ambrosioni, E. Strocchi
    Pages 107-114

  18. Phase IV: the opportunity and the challenge

    • L. Lasagna
    Pages 115-118

  19. Concordance of clinical and marketing objectives in phase IV

    • J. J. Schrogie
    Pages 119-125

  20. Exploring the clinical properties of marketed drugs

    • E. S. Snell
    Pages 126-135
Back to top

Keywords

About this book

This book is the edited proceedings of the 6th International Meeting of Pharmaceutical Physicians (IFAPP) held at Brighton, UK in 1987. It covers a wide range of topics of concern and interest to pharmacologists and pharmaceutical physicians, including current issues such as improving post-marketing surveillance, the use and abuse of phase IV trials, health care and clinical trials in developing countries.

Editors and Affiliations

  • Ciba-Geigy Pharmaceuticals, IFAPP, Horsham, England

    Denis Burley

Bibliographic Information

  • Book Title: The Focus for Pharmaceutical Knowledge

  • Book Subtitle: The Proceedings of the Sixth International Meeting of Pharmaceutical Physicians Brighton, England, June 1987

  • Editors: Denis Burley, Christobel Haward, Brenda Mullinger

  • DOI: https://doi.org/10.1007/978-1-349-09571-1

  • Publisher: Red Globe Press London

  • eBook Packages: Biomedical and Life Sciences, Biomedical and Life Sciences (R0)

  • Copyright Information: The International Federation of Associations of Pharmaceutical Physicians 1988

  • Edition Number: 1

  • Number of Pages: XVI, 315

  • Additional Information: Previously published under the imprint Palgrave

  • Topics: Pharmacology/Toxicology, Pharmacy

Publish with us

Policies and ethics

Back to top

Search

Navigation